Clinical Trial Update: Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca [Phase 3]

View source ↗

Summary

This document provides an update on a Phase III trial comparing high-dose versus standard-dose Vitamin D2 in combination with docetaxel for metastatic breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• ergocalciferol (ergocalciferol)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN